Newly surfaced documents and reporting are fueling questions about whether a small network of powerful players including Bill Gates, Jeffrey Epstein, and individuals linked to Robert Maxwell’s scientific publishing legacy sought outsized influence over how research is distributed and amplified. Emails, investments, and media-funding ties are being cited as potential indicators of an effort to shape which scientific ideas rise to prominence and which get sidelined. The broader issue: who controls the pipelines of modern science—publishing, PR, and perception—and what transparency is owed to the public when power concentrates behind the scenes.